NASDAQ Equity Snapshot
CRVS Weekly Equity Report
Corvus Pharmaceuticals Inc
What the company does
Corvus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology therapies. The company is headquartered in Burlingame, California.
What the weekly tape is saying
CRVS closed the latest completed week at 11.93 USD. The 4-week return is -3.1% and the 12-week return is -10.5%. Trend Signal is inactive, Market Dynamics is -1.04. Setup signature: Risk-first tape with a 30/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 13.48 USD
- Vs Trend Line
- -11.5%
- Fair Value
- 5.66 USD
- Vs Fair Value
- 110.6%
- 52W High
- 26.95 USD
- 52W Low
- 3.55 USD
- Drawdown
- -55.7%
- Range Position
- 35.8%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 40
- 52W Active Breadth
- 76.9%
- Sector Scope
- US Healthcare
- Sector Rank
- 186 of 1038
- Sector Percentile
- 82.2%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -1.04
- 4W MD Change
- -44.4%
- Relative Strength
- -0.17
- 4W RS Change
- -101.8%
- Expectation
- Positive
- Probability
- 59.18%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 6.2M
- 13W Average
- 7.3M
- 52W Average
- 8.0M
- Vs 13W
- 0.9x
- Vs 52W
- 0.8x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 8.5%
- 52W Volatility
- 30.5%
- Upside Weeks
- 27
- Downside Weeks
- 25
- Downside Breadth
- 48.1%
- Avg Gain / Loss
- 15.0% / -7.2%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 1.1B
Opportunity signals
- Price is above Fair Value, showing premium demand versus the model.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 11.93 USD | 7.3% | 13.48 USD | 5.66 USD | -1.04 | -0.17 | 6.2M | Off |
| 5 Jun 2026 | 11.12 USD | -10.4% | 13.38 USD | 5.60 USD | -0.96 | -3.85 | 7.1M | Off |
| 29 May 2026 | 12.41 USD | -1.6% | 13.26 USD | 5.55 USD | -0.82 | 3.49 | 7.2M | Off |
| 22 May 2026 | 12.61 USD | 2.4% | 13.11 USD | 5.50 USD | -0.81 | 9.43 | 12.0M | On |
| 15 May 2026 | 12.31 USD | -20.8% | 12.94 USD | 5.43 USD | -0.72 | 9.52 | 10.9M | On |
| 8 May 2026 | 15.55 USD | 0.6% | 12.76 USD | 5.37 USD | -0.59 | 39.67 | 5.9M | On |
| 1 May 2026 | 15.46 USD | -3.9% | 12.48 USD | 5.29 USD | -0.49 | 48.82 | 5.9M | On |
| 24 Apr 2026 | 16.08 USD | -3.9% | 12.20 USD | 5.19 USD | -0.33 | 60.29 | 9.7M | On |
| 17 Apr 2026 | 16.74 USD | 10.9% | 11.91 USD | 5.10 USD | -0.26 | 74.39 | 5.9M | On |
| 10 Apr 2026 | 15.10 USD | 2.8% | 11.55 USD | 5.00 USD | -0.23 | 71.14 | 3.3M | On |
| 2 Apr 2026 | 14.69 USD | 4.9% | 11.24 USD | 4.91 USD | -0.11 | 78.22 | 4.5M | On |
| 27 Mar 2026 | 14.01 USD | 5.1% | 10.95 USD | 4.82 USD | 0.03 | 81.28 | 5.8M | On |
| 20 Mar 2026 | 13.33 USD | -13.0% | 10.68 USD | 4.74 USD | 0.23 | 71.14 | 10.2M | On |
| 13 Mar 2026 | 15.32 USD | -3.0% | 10.42 USD | 4.66 USD | 0.40 | 96.76 | 5.8M | On |